Literature DB >> 20131069

Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain.

Samira S Valvassori1, Morgana Moretti, Marcia Kauer-Sant'Anna, Rafael Roesler, Fabrícia Petronilho, Gilberto Schwartsmann, Flavio Kapczinski, Felipe Dal-Pizzol, João Quevedo.   

Abstract

Previous studies have suggested that bipolar disorder may be associated with oxidative stress. Administration of D: -amphetamine (AMPH) has been put forward as an animal model of mania, and has shown to increase oxidative stress parameters in the rat brain. Thus, we have used the gastrin-releasing peptide receptor antagonist [D-Tpi(6)Leu(13)psi (CH(2)NH)-Leu(14)] bombesin (RC-3095) as a pharmacological tool to investigate the role of bombesin-like peptides in the redox balance in the hippocampus and cortex of rats treated with AMPH. Rats were given a single 10 ml/kg intraperitoneal (i.p.) injection of saline (SAL) or RC-3095 (0.1, 1.0 or 10.0 mg/kg) followed by an i.p. injection of SAL or amphetamine (AMPH 2.0 mg/kg) 30 min later. Locomotor activity was evaluated 2 h after the last drug injection. The thiobarbituric acid reactive substances (TBARS), protein carbonyl formation, superoxide dismutase and catalase (CAT) activity were measured in hippocampus, striatum and cortex as markers of oxidative stress. The results show that RC-3095 blocks AMPH-induced hyperlocomotion. Moreover, specific doses of RC-3095 alone increased the levels of oxidative stress in the dorsal hippocampus and cortex. However, when AMPH was subsequently administrated, RC-3095 decreased TBARS and protein carbonyls formation and increased the superoxide dismutase and CAT activity in the hippocampus, striatum and cortex. The effects of GRPR antagonist seemed to be region and dose specific. In conclusion, the results suggest that GRPR antagonists might display antioxidant properties in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20131069     DOI: 10.1007/s00702-010-0373-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  34 in total

1.  Pro and antioxidant responses to repeated administration of diazepam in rat brain.

Authors:  S Musavi; P Kakkar
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  Evidence of astrogliosis in rat hippocampus after d-amphetamine exposure.

Authors:  Benício N Frey; Ana C Andreazza; Keila M Ceresér; Márcio R Martins; Fabrícia C Petronilho; Daniela F de Souza; Francine Tramontina; Carlos A Gonçalves; João Quevedo; Flávio Kapczinski
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-04-21       Impact factor: 5.067

Review 3.  Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases.

Authors:  Gary E Gibson; Hsueh-Meei Huang
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

4.  Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus.

Authors:  R Roesler; T Luft; S H S Oliveira; C B Farias; V R Almeida; J Quevedo; F Dal Pizzol; N Schröder; I Izquierdo; G Schwartsmann
Journal:  Neuropharmacology       Date:  2006-06-02       Impact factor: 5.250

5.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report.

Authors:  Benício N Frey; Ana C Andreazza; Maurício Kunz; Fabiano A Gomes; João Quevedo; Mirian Salvador; Carlos Alberto Gonçalves; Flávio Kapczinski
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-07-20       Impact factor: 5.067

7.  Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis.

Authors:  Felipe Dal-Pizzol; Luciane Pons Di Leone; Cristiane Ritter; Márcio Rodrigo Martins; Adalisa Reinke; Daniel Pens Gelain; Alfeu Zanotto-Filho; Luiz Fernando de Souza; Michael Andrades; Denise Frediani Barbeiro; Elena Aida Bernard; Martin Cammarota; Lia R M Bevilaqua; Francisco Garcia Soriano; José Cláudio; Fonseca Moreira; Rafael Roesler; Gilberto Schwartsmann
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

8.  Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.

Authors:  Benicio N Frey; Samira S Valvassori; Gislaine Z Réus; Márcio R Martins; Fabrícia C Petronilho; Katrine Bardini; Felipe Dal-Pizzol; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 9.  Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy.

Authors:  D B Cornelio; R Roesler; G Schwartsmann
Journal:  Ann Oncol       Date:  2007-03-09       Impact factor: 32.976

10.  Product of extracellular-superoxide dismutase catalysis.

Authors:  S L Marklund
Journal:  FEBS Lett       Date:  1985-05-20       Impact factor: 4.124

View more
  3 in total

1.  Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats.

Authors:  Dayane D da-Rosa; Samira S Valvassori; Amanda V Steckert; Camila O Arent; Camila L Ferreira; Jéssica Lopes-Borges; Roger B Varela; Edemilson Mariot; Felipe Dal-Pizzol; Monica L Andersen; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-08-20       Impact factor: 3.575

2.  Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors.

Authors:  Camila O Arent; Samira S Valvassori; Gabriel R Fries; Laura Stertz; Camila L Ferreira; Jéssica Lopes-Borges; Edemilson Mariot; Roger B Varela; Felipe Ornell; Flávio Kapczinski; Monica L Andersen; João Quevedo
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

3.  Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain.

Authors:  Yi Che; Yong-Hua Cui; Hua Tan; Ana C Andreazza; L Trevor Young; Jun-Feng Wang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-01       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.